View drug registration information details.
Items | Registration information |
ID | 420 |
No | 420 |
Brand Name | ARICEPT EVESS 5 MG |
Ingredients | DONEPEZIL HYDROCHLORIDE 5 MG EQ.TO DONEPEZIL FREE BASE 4.56 MG |
Dosage Form | TABLET |
Primary Packaging | BLISTERPACK |
Storage | DO NOT STORE ABOVE 30'C |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 28,30,56,60,98 OR 120 TABLETS |
Dispensing Category | Prescription only |
ATC Classification | N06DA02 |
Pharmaceutical Class | DEMENTIA |
Indications | SYMPTOMATIC TREATMENT OF MILD, MODERATELY SEVERE AND SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE, VASCULAR DEMENTIA ( DEMENTIA ASSOCIATED WITH CEREBROVASCULAR DISEASE), DEMENTIA WITH LEWY BODIES( DLB). |
Contraindications | ARICEPT IS CONTRAINDICATED IN PATIENTS WITH A KNOW HYPERSENSITIVITY TO DONEPEZIL HYDROCHLORIDE, PIPERIDINE DERIVATIVES, OR TO ANY EXCIPIENTS USED IN THE FORMULATION. |
Side Effects | THE MOST COMMON ADVERSE EVENTS ARE DIARRHOEA, MUSCLE CRAMPS,FATIGUE, NAUSEA, VOMITING AND INSOMNIA. |
Unit Price | - |
EDL |
No |
Description | WHITE, ROUND TABLETS DEBOSSED ARICEPT ON ONE SIDE AND 5 ON THE OTHER |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | BUSHU PHARMACEUTICALS LTD. MISATO FACTORY |
Country | THAILAND |
Import Registration No | 1B 5/52( N) |
Import Registration Date | 2009-11-27 |
Activity | CERTIFICATE RELEASED |
Applied Date | 09-ARP-2022 |
FDD Registration No | 03 I 3781/12 |
FDD Registration Date | 2022-09-14 |
Expiry Date | 2025-09-13 |
Back to drug list
|